Fighting liver cancer takes big financial toll: Study
Out-of-pocket costs can leave Medicare patients with the most common type of liver cancer in financial distress.
Feb 2, 2023
0
9
Out-of-pocket costs can leave Medicare patients with the most common type of liver cancer in financial distress.
Feb 2, 2023
0
9
In non-cirrhotic liver diseases, organ transplantation in two steps, especially with a living donation, is a safe therapy option for donors and recipients. This is the conclusion of a case series evaluated by surgeons from ...
Jan 31, 2023
0
2
Smartphone-based assessment of jaundice in patients with decompensated cirrhosis is feasible and accurate, mirroring levels of bilirubin and its correlations with clinical parameters, according to a study published online ...
Jan 11, 2023
0
2
Opioids are frequently prescribed to patients with cirrhosis, often without a pain diagnosis, according to a research letter published online Dec. 8 in Clinical Gastroenterology and Hepatology.
Dec 29, 2022
0
11
Dr. Jawaher Alharthi, from the Westmead Institute and medical research, University of Sydney, Australia, and her colleagues have discovered how COVID-19 increases the risk of fatty liver disease and how the latter is increasing ...
Dec 15, 2022
0
62
Complete abstinence from alcohol is considered a cornerstone in the treatment of patients with alcohol-related liver disease. It has not yet been sufficiently researched whether this measure can still improve the prognosis ...
Dec 13, 2022
0
13
Approximately one-fourth of the general population worldwide has nonalcoholic fatty liver disease, known as NAFLD, an umbrella term for a range of liver conditions affecting people who drink little to no alcohol. NAFLD can ...
Nov 1, 2022
0
44
Scientists at deCODE genetics, a subsidiary of Amgen, published today a large genome-wide association study on nonalcoholic fatty liver disease (NAFLD) in Nature Genetics. Sequence variants that associate with NAFLD were ...
Oct 24, 2022
0
19
Cirrhosis of the liver is associated with decreased responsiveness to COVID-19 mRNA vaccines as evidenced by results after two doses. However, the results of a new study strongly support giving the recommended booster vaccinations ...
Oct 19, 2022
0
14
Researchers at CeMM, the Medical University of Vienna (MedUni Vienna), and the Ludwig Boltzmann Institute for Rare and Undiagnosed Diseases (LBI-RUD) joined efforts to use their expertise in machine learning and management ...
Oct 4, 2022
0
6